Soluble Monospecific Tetrameric Antibody Complexes for T/NK Cell Expansion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for T cell and NK cell activation and expansion often require immobilized antibodies, accessory cells, and exogenous growth factors, leading to potential cell death and inefficiencies, while soluble bispecific tetrameric antibody complexes have not been fully demonstrated as soluble and lack optimal activation efficiency.
Innovation Solution
The use of soluble monospecific tetrameric antibody complexes that bind to the same antigen on T or NK cells, enhancing activation and expansion by avoiding immobilization requirements and improving activation efficiency compared to bispecific complexes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If immobilized anti-CD3 antibodies are used for T cell activation, then T cell activation and expansion can be achieved, but the requirement for specialized surfaces and immobilization reduces ease of operation and increases device complexity
Solution Approach 1:
The patent changes the physical state parameter of the antibodies from immobilized (fixed on surfaces) to soluble (free in solution). This parameter change eliminates the need for specialized coated surfaces while maintaining T cell activation capability, as the soluble antibodies can freely interact with T cells in culture medium.
Solution Approach 2:
The patent extracts the antibodies from their traditional immobilized state on specialized surfaces and places them directly into the culture medium in soluble form. This extraction eliminates the dependency on coated plates or magnetic beads, simplifying the activation system to just the antibodies and cells in standard culture conditions.
2Reliability
If soluble bisspecific tetrameric antibody complexes are used, then T cell activation may be achieved, but the solubility and activation efficiency have not been fully demonstrated or optimized
Solution Approach 1:
The patent segments the bispecific tetrameric complex into separate monospecific antibodies that can be independently characterized and optimized. By using combinations of soluble monospecific antibodies rather than complex bispecific tetramers, the system achieves demonstrated solubility and optimized activation efficiency through controlled combinations of simpler, well-characterized components.
Solution Approach 2:
Instead of attempting to create and characterize complex soluble bisspecific tetrameric complexes (the conventional approach), the patent inverts the approach by using separate soluble monospecific antibodies. This inversion simplifies the molecular complexity while achieving the desired activation effect through combinatorial use of simpler components.
3Productivity
If accessory cells and exogenous growth factors are used for T cell expansion, then T cell proliferation can be enhanced, but the requirement for continuous replenishment of accessory cells and growth factors increases device complexity and reduces ease of operation
Solution Approach 1:
The patent enables the T cell system to be self-sufficient by using soluble antibodies that directly stimulate T cell activation and proliferation without requiring external accessory cells or continuous addition of growth factors. The soluble antibodies provide all necessary stimulation signals, allowing the system to maintain itself through the antibody's persistent presence in the culture medium.
Solution Approach 2:
The soluble antibodies perform multiple functions simultaneously: they provide antigen recognition signals through anti-CD3 activity, costimulation through anti-CD28 activity, and sustain prolonged stimulation without requiring additional components. This multi-functionality replaces the need for separate accessory cells and growth factors with a single versatile reagent system.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Soluble monospecific tetrameric antibody complexes provide enhanced T cell and NK cell proliferation, cytokine production, and expansion, reducing the need for specialized surfaces and maintaining cell viability, with improved activation outcomes compared to traditional methods.
Implementation Method 1
soluble monospecific tetrameric antibody complexes that bind to the same antigen on T or NK cells
Implementation Method 2
Anti-CD3 initiates the activation and proliferation signaling cascade by crosslinking the components of the T cell receptor complex on the surface of T cells
Data Source
AI summary
This disclosure provides compositions and methods for the activation and expansion of human T cells or NK cells using soluble monospecific antibody complexes.